Analysis of the competitiveness of the biological pharmaceutical industry on the example of the United States
- Authors: Wang K.1, Solovieva Y.V.1
-
Affiliations:
- RUDN University
- Issue: Vol 31, No 2 (2023): CHALLENGES FOR SUSTAINABLE DEVELOPMENT: GLOBAL PARTNERSHIP IN A NEW ENVIRONMENT
- Pages: 238-252
- Section: INDUSTRIAL ORGANIZATION MARKETS
- URL: https://journals.rcsi.science/2313-2329/article/view/324330
- DOI: https://doi.org/10.22363/2313-2329-2023-31-2-238-252
- EDN: https://elibrary.ru/BMWFZA
- ID: 324330
Cite item
Full Text
Abstract
Since entering the era of bioeconomy, the biotechnology industry economy represented by the bio pharmaceutical industry is leading a new wave of technological revolution. China’s strategic deployment for the bio pharmaceutical industry economy has achieved remarkable results, but there is still a large competitive gap compared with the United States and other biomedical powers. The goal of this article is to study the American biomedical market and find out the gap, so as to provide inspiration for the development of the biomedical industry in China and other countries. The Porter Diamond Model is used to build the theoretical research method analysis framework of the international competitiveness of the bio pharmaceutical industry. Taking the United States as an example, the paper analyzes its competitive advantages in six aspects: the elements of the biomedical industry, the enterprise structure and competition, the demand conditions, the relevant and supporting industries, the government and development opportunities. Based on this, the paper puts forward policy recommendations conclusions for China’s development of the bio pharmaceutical industry, so as to provide reference value for the development of the pharmaceutical industry.
About the authors
Kexin Wang
RUDN University
Email: 1042218199@pfur.ru
Graduate student of the Department of National Economics, Faculty of economics 6 Miklukho-Maklaya St, Moscow, 117198, Russian Federation
Yuliana V. Solovieva
RUDN University
Author for correspondence.
Email: solovyeva-yuv@rudn.ru
ORCID iD: 0000-0002-1437-0008
кандидат экономических наук, доцент, доцент кафедры национальной экономики экономического факультета
6 Miklukho-Maklaya St, Moscow, 117198, Russian FederationReferences
- Carlson, R. (2016). Estimating the biotech sector’s contribution to the US economy. Nature Biotechnology, 34(3), 247-255. https://doi.org/10.1038/nbt.3491
- Chung, T.W. (2016). A study on logistics cluster competitiveness among Asia main countries using the Porter’s Diamond Model. The Asian Journal of Shipping and Logistics, 32(4), 257-264. https://doi.org/10.1016/j.ajsl.2016.12.010
- Fang, K., Zhou, Y.H, & Wang, S. (2018). Assessing national renewable energy competitiveness of the G20: A revised Porter’s Diamond Model. Renewable and Sustainable Energy Reviews, 93(1), 719-731. https://doi.org/10.1016/j.rser.2018.05.011
- Graul, A.I., Pina, P., & Cruces, E. (2019). 2018 Global New Drug R&D Report Part 1: New Drugs and Biological Agents. Pharmaceutical Progress, 41(4), 309-317. https://doi.org/10.1358/dot.2019.55.1.2959663
- Guo, Z.P. (2020). Current situation and development of research on biological drugs and biological analogues. Journal of Clinical Pharmacotherapy, 18(5), 1-6.
- Hernández, H., Grassano, N., & Tübke A. (2019). The 2019 EU industrial R&D investment scoreboard. (p. 62). Luxembourg: Publications Office of the European Union. https://doi.org/10.2760/04570
- Hodgson, J. (2020). The pandemic pipeline. Nature Biotechnology, 38(5), 523-532. https://doi.org/10.1038/d41587-020-00005-z
- Huang, Wei (2006). Research on Venture Capital Model of Biomedical Industry [dissertation]. China, Shanghai: Fudan University.
- Ji, Lei, Li, H.Y, & Wang, Y. (2019). Analysis on the competitiveness of Shandong marine bio pharmaceutical industry based on the diamond model. Fisheries Research, 41(5), 430-440. http://www.hyyysci.com/EN/Y2019/V41/I5/430
- Irfan, M., Zhao, Z.Y., & Ahmad, M. (2019). Critical factors influencing wind power industry: A Diamond Model based study of India. Energy Reports, 5(1), 1222-1235. https://doi.org/10.1016/j.egyr.2019.08.068
- Lindburg, L., Bozinovic, L., & Susek, R. (2019). As the life science industry evolves, so do its talent needs. Nature Biotechnology, 37(4), 481-483. https://doi.org/10.1038/s41587-019-0091-5
- Morrison, C. (2020). 2019 Biotech IPOs: Party on. Nature Reviews Drug Discovery, 49(1), 6-9. https://doi.org/10.1038/d41573-019-00213-6
- Ozer K.O., Latif, H., & Sariisik, M. (2012). International competitive advantage of Turkish tourism industry: A comparative analysis of Turkey and Spain by using the Diamond Model of M. Porter. Procedia-Social and Behavioral Sciences, 58(1), 1064-1076. https://doi.org/10.1016/j.sbspro.2012.09.1087
- Porter, M. (2002). National Competitive Advantage. Beijing Hua Xia Publishing House. Pp. 123-136.
- Qian, J.Y., & Yu, Zheng (2020). Analysis on the international competitiveness of China’s biopharmaceutical industry. China Pharmaceutical Affair, 34(5), 549-555. https://doi.org/10.16153/j.1002-7777.2020.05.008
- Shi, G., & Liu, F.Y. (2016). Current situation and countermeasures of China’s biomedical industry development. China Health Policy Research, 9(3), 16-19.
- Wang, F. (2019). Upgrading Law and Enlightenment of Innovation in American Biomedical Industry. Nanjing Social Sciences, 30(8), 29-35.
- Zhao, B., Zhang, D.S., & Zhao, Y.Z. (2011). Research on the competitiveness of regional biomedical industry based on the diamond model: take Shijiazhuang as an example. Chinese Journal of Bioengineering, 31(9), 140-145. https://manu60.magtech.com.cn/biotech/CN/Y2011/V31/I9/140
- Zhang, Qing (2011). Development Characteristics and Enlightenment of American Biomedical Industrial Park. China Hi-tech Zone, 11(4), 111-113.
- Zhang, J.C. (2001). Research on Theory and Method of International Competitiveness Evaluation [dissertation]. China, Beijing: Graduate School of Chinese Academy of Social Sciences.
- Zhang, J.R. (2015). Experience and Inspiration of the Development of American Biomedical Industry. Business Research, 39(12), 24-28.
- Zheng, X.F. (2011). Innovation of American Biotechnology Industry Cluster and Its Inspiration to China. Journal of Hainan University (Humanities and Social Sciences Edition), 29(3), 50-54. https://doi.org/10.3969/j.issn.1004-1710.2011.03.009
- Zhu, Xing, & Xu, Fu (2015). Research on distribution and trend of biomedical patents. Chinese Journal of New Drugs, 24(15), 1686-1693. www.cqvip.com/qk/97417x/201515/665635479.html
Supplementary files
